Reliance Life Sciences Private Limited Recalls

4 recalls found for Reliance Life Sciences Private Limited — June 2026.

Medications: 4

The recalls listed below are active notices associated with Reliance Life Sciences Private Limited in the FDA, NHTSA, USDA, and CPSC databases. None of the current recalls are classified as urgent. The current recalls involve sterility concerns. Check the specific lot numbers, model numbers, or production date codes in each notice carefully — a recall typically covers specific production runs, not everything a manufacturer sells.

A manufacturer appearing in the recall database does not indicate an ongoing safety failure. High-volume companies with large product lines naturally appear more frequently. What matters is whether your specific product — identified by lot number, model number, or date code — is included in a recall notice.

Browse all medication recalls
NoticeMedications

Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactur

Reliance Life Sciences Private Limited

Lack of Sterility Assurance

View recall →
NoticeMedications

Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for:

Reliance Life Sciences Private Limited

Lack of Sterility Assurance

View recall →
NoticeMedications

Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactur

Reliance Life Sciences Private Limited

Lack of Sterility Assurance

View recall →
NoticeMedications

Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx onl

Reliance Life Sciences Private Limited

Lack of Sterility Assurance

View recall →